Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/02/2014 | US8901277 Interferon alpha mutant and its polyethylene glycol derivative |
12/02/2014 | US8901084 Self-assembling peptide incorporating modifications and methods of use thereof |
12/02/2014 | US8901083 Administration of angiocidin for the treatment of leukemia |
12/02/2014 | US8901082 Immunity-inducing agent and method for detection of cancer |
12/02/2014 | US8901079 Treatment of parkinson's disease via administration of GLI-1 protein |
12/02/2014 | US8901077 Delivery of a gene therapy vector to the brain by convection-enhanced delivery |
12/02/2014 | US8901076 Binding proteins inhibiting the VEGF-A receptor interaction |
12/02/2014 | US8901074 Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases |
12/02/2014 | US8901073 Compounds and their effects on feeding behaviour |
12/02/2014 | US8901070 Pharmaceutical compositions comprising pore-forming proaerolysin protein (PRX302) |
12/02/2014 | US8901069 Protein matrix for light-initiated electron transfer |
12/02/2014 | US8900880 Viral citrullinated peptides and uses thereof |
12/02/2014 | US8900846 Nucleic acid modifying enzymes |
12/02/2014 | US8900825 Immunogenic proteins of Leptospira |
12/02/2014 | US8900600 Identification, optimization and use of cryptic HLA-A24 epitopes for immunotherapy |
12/02/2014 | US8900599 Conjugates of Plasmodium falciparum surface proteins as malaria vaccines |
12/02/2014 | US8900597 Compositions relating to a mutant Clostridium difficile toxin and methods thereof |
12/02/2014 | US8900596 Physicochemical (PCP) based consensus sequences and uses thereof |
12/02/2014 | US8900595 Filovirus vectors and noninfectious filovirus-based particles |
12/02/2014 | US8900594 Oral recombinant Helicobacter pylori vaccine and preparing method thereof |
12/02/2014 | US8900593 Glucagon/GLP-1 receptor co-agonists |
12/02/2014 | US8900591 Vaccines comprising mutant GPCRs with increased conformational stability relative to parent receptors |
12/02/2014 | US8900589 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds |
12/02/2014 | US8900584 Human CDR-grafted antibody and antibody fragment thereof |
12/02/2014 | US8900583 Methods for treatment of brain injury utilizing biologics |
11/27/2014 | US20140352001 Novel bacillus thuringiensis gene with lepidopteran activity |
11/27/2014 | US20140352000 Novel bacillus thuringiensis gene with lepidopteran activity |
11/27/2014 | US20140351998 Engineering plants for efficient uptake and utilization of urea to improve crop production |
11/27/2014 | US20140351967 Brassica Plant Comprising a Mutant Indehiscent Allele |
11/27/2014 | US20140351960 Artery- and vein-specific proteins and uses therefor |
11/27/2014 | US20140350453 Bonding tissues and cross-linking proteins with naphthalimide compounds |
11/27/2014 | US20140350229 Method for producing synthetic amylospheroid |
11/27/2014 | US20140350223 Enhanced production and purification of a natural high intensity sweetener |
11/27/2014 | US20140350220 NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN; pE) |
11/27/2014 | US20140350218 Alpha-conotoxin peptides |
11/27/2014 | US20140349946 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
11/27/2014 | US20140349944 Chaperone-based integrin inhibitors for the treatment of cancer and inflammatory diseases |
11/27/2014 | US20140349940 Prevention and reduction of blood loss |
11/27/2014 | US20140349929 Multivalent fibronectin based scaffold domain proteins |
11/27/2014 | US20140349925 Novel insulin derivatives |
11/27/2014 | US20140349917 Targeted antimicrobial moieties |
11/27/2014 | US20140349893 Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes |
11/27/2014 | US20140349855 T cell receptor display |
11/27/2014 | US20140349371 Protein Refolding Method |
11/27/2014 | US20140349344 Compositions and methods for purifying bax |
11/27/2014 | US20140349315 Disulphide bond-stabilized functional soluble mhc class ii heterodimers |
11/27/2014 | US20140348904 Exosomes With Transferrin Peptides |
11/27/2014 | US20140348902 Tcl1 peptides for immunotherapy |
11/27/2014 | US20140348870 Immunogenic plasmodium falciparum antigen compositions and uses thereof |
11/27/2014 | US20140348869 Modified meningococcal fhbp polypeptides |
11/27/2014 | US20140348868 Compositions comprising pneumococcal antigens |
11/27/2014 | US20140348867 Isolated Brachyspira and Methods and Compositions for Expanding and Isolating Brachyspira |
11/27/2014 | US20140348865 Immunogens based on an hiv-1 v1v2 site-of-vulnerability |
11/27/2014 | US20140348864 Porcine circovirus type-2 (pcv2) subunit vaccine |
11/27/2014 | US20140348863 Cmv antigens and uses thereof |
11/27/2014 | US20140348862 Prame derived peptides and immunogenic compositions comprising these |
11/27/2014 | US20140348861 Synthetic peptides and random copolymers for the treatment of autoimmune disorders |
11/27/2014 | US20140348859 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules |
11/27/2014 | US20140348854 HE4 Based Therapy For Malignant Disease |
11/27/2014 | US20140348842 Tim-3 ligands and methods thereof |
11/27/2014 | US20140348832 Inhibitors of t-cell activation |
11/27/2014 | US20140348826 Engineering multifunctional and multivalent molecules with collagen xv trimerization domain |
11/27/2014 | US20140348817 Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof |
11/27/2014 | US20140348805 High affinity t cell receptor and use thereof |
11/27/2014 | US20140348798 Seneca valley virus based compositions and methods for treating disease |
11/27/2014 | US20140348794 Aav4 vector and uses thereof |
11/27/2014 | US20140348790 Adeno-associated virus serotype i nucleic acid sequences, vectors and host cells containing same |
11/27/2014 | US20140348784 Compositions and methods for treatment of angiogenesis in pathological lesions |
11/27/2014 | US20140348781 Conjugates of gm-csf and il-9, compositions and methods related thereto |
11/25/2014 | US8898047 Methods for identifying inhibitors against viruses that use a class I fusion protein |
11/25/2014 | US8895818 Transgenic plants with enhanced agronomic traits |
11/25/2014 | US8895807 RabG3b gene and protein thereof for regulating late stage xylem development, method for promoting plant biomass and transgenic plant comprising the same |
11/25/2014 | US8895715 S100B mini-promoters |
11/25/2014 | US8895713 Clostridial neurotoxins with altered persistency |
11/25/2014 | US8895711 Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP) |
11/25/2014 | US8895705 Antibodies against a proliferating inducing ligand (APRIL) and methods of use thereof |
11/25/2014 | US8895703 CA125 gene and its use for diagnostic and therapeutic interventions |
11/25/2014 | US8895701 Peptide-conjugated oligonucleotide therapeutic and method of making and using same |
11/25/2014 | US8895700 Monkey homolog of human interferon omega |
11/25/2014 | US8895699 Stabilized compounds having secondary structure motifs |
11/25/2014 | US8895694 Glucagon-Like Peptide-1 derivatives and their pharmaceutical use |
11/25/2014 | US8895598 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection |
11/25/2014 | US8895507 Modulation of synaptogenesis |
11/25/2014 | US8895504 Amylin derivatives |
11/25/2014 | US8895503 Pharmaceutical composition for transnasal administration of peptide hormones or cytokines |
11/25/2014 | US8895502 β2-glycoprotein I peptide inhibitors |
11/25/2014 | US8895500 Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof, and method for preparing same |
11/25/2014 | US8895498 GIP and exendin hybrid polypeptides |
11/25/2014 | US8895309 Myostatin inhibition for enhancing muscle and/or improving muscle function |
11/25/2014 | US8895303 Method of cell culture and method of treatment comprising a vEPO protein variant |
11/25/2014 | US8895286 Attenuated pestiviruses |
11/25/2014 | US8895284 Class II human histone deacetylases, and uses related thereto |
11/25/2014 | US8895283 Nucleic acid modifying enzymes |
11/25/2014 | US8895282 Use of a substance for manufacturing of a medicament for treatment of common cold |
11/25/2014 | US8895281 Method for preparing a site-specific physiologically active polypeptide conjugate |
11/25/2014 | US8895277 Legume isoprene synthase for production of isoprene |
11/25/2014 | US8895276 Microorganism variants having hydrocarbon producing ability and method for producing hydrocarbon using the same |
11/25/2014 | US8895272 Methods for the economical production of biofuel from biomass |
11/25/2014 | US8895263 Methods for suppressing toll-like receptor activity |
11/25/2014 | US8895257 Proteins used for the diagnosis of lyme borreliosis |